Pharma Execs Slam Abortion Pill Ruling, Citing Industry Risk

By Emily Field (April 10, 2023, 3:20 PM EDT) — Chief executive officers and top legal counsel for pharmaceutical and biotech companies, including Pfizer, said a Texas federal judge’s Friday order blocking the effective date of the U.S. Food and Drug Administration’s decades-old approval of the abortion drug mifepristone fundamentally undermines the agency’s authority and threatens industry….

Read more

Explore the site

More from the blog

Latest News